Indeferimento
#9.2
05/13/2025
RPI 2836
Back to search
Utility Model USO DE UM ANTICORPO ANTI-CD38 de JANSSEN BIOTECH, INC. — IPC C07K 16/00. Drawing published by the INPI in the Industrial Property Gazette.
Official data from INPI
USO DE UM ANTICORPO ANTI-CD38
IndeferidaUtility ModelPCT · US2015017420
Application data
Number
122024010998Type
Utility Model
Filing
02/25/2015
Publication
07/16/2024
PCT
US2015017420 Progress at the INPI
Under appeal- Filing02/25/15
- Publication07/16/24
- Examination
- Refused05/13/25
- Grant
- In force
The application was refused by the INPI on 05/13/2025. The invention was never patented.
Talk to a specialistLatest action published by the INPI: 05/13/2025. We update with every new RPI gazette, published weekly.
Applicants and inventors
Applicants
JANSSEN BIOTECH, INC.
US
Inventors
P. D. (pessoa física)
US
Technical data
IPC Classification
Priority claims
US
61/946,002 · 02/28/2014
US
62/006,386 · 06/02/2014
Abstract
USO DE UM ANTICORPO ANTI-CD38. A presente invenção refere-se a terapias de combinação com anticorpos anti-CD38.
Prosecution history
Publications in the Brazilian Industrial Property Gazette (RPI).
Conhecimento de parecer técnico
#7.1
01/07/2025
RPI 2818
Publicação do pedido de patente
#3.1
07/16/2024
RPI 2793
Notificação de pedido dividido
#2.4
06/25/2024
RPI 2790
Requerimento de pedido de patente
#2.10
Número de Protocolo '870240046293' em 31/05/2024 17:03 (WB)
06/11/2024
RPI 2788
Related
From the same holder
Same category
Patent monitoring
Track this patent in real time.
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.